Characterization of UDP-glucuronosyltransferase (UGT1A1) Promoter Polymorphisms and Gene Expression on Ethnicity, Stage of Disease, and Menopausal Status in Breast Cancer
- PMID: 30349745
- PMCID: PMC6195800
- DOI: 10.4172/2157-7609.S4-001
Characterization of UDP-glucuronosyltransferase (UGT1A1) Promoter Polymorphisms and Gene Expression on Ethnicity, Stage of Disease, and Menopausal Status in Breast Cancer
Abstract
Estrogen metabolism, catalyzed by UGTs, is a major drug-metabolic pathway that results in inactivation of estrogens and their metabolites. Alterations in UGTs involved in estrogen metabolism, has been suggested to play a role in breast cancer risk. The purpose of this study was to: 1) compare the mRNA expression levels of UGTs involved in estrogen metabolism in human breast tissues from women; 2) compare UGT1A1 mRNA expression to tumor stage, ethnicity, and menopausal status in a group of human breast tumors and normal breast tissues, and 3) investigate the association between variations in the number of TA repeats in the promoter region of UGT1A1 to gene expression. Quantification of UGT mRNA in breast tissues revealed that UGT1A4, UGT1A10, and UGT2B7 mRNA levels were decreased in breast cancers as compared to normal breast tissues. UGT1A1 mRNA levels were also significantly decreased in breast cancers as compared to normal breast tissues (Tumor: 0.5 ± 0.2; Normal: 4.1 ± 1.3, p = 0.0006). UGT1A1 mRNA down-regulation was strongly correlated with postmenopausal status in breast cancer versus controls (p = 0.04). In all the UGT1A1 genotypes observed in our study, the mean mRNA levels was significantly decreased among breast cancer cases as compared to controls for UGT1A1*1/*1 (p = 0.004), UGT1A1*28/*28 (p = 0.03) and UGT1A1*28/*37 (p = 0.06). Our findings demonstrate that further investigations are necessary to determine the role of UGT1A1 in breast carcinogenesis.
Keywords: Breast cancer; Genetic polymorphism; UGT1A1; UGTs.
Figures


Similar articles
-
Prevalence of the UGT1A1*28 promoter polymorphism and breast cancer risk among African American women in Memphis, TN.Cancer Health Disparities. 2019 Aug 19;3:e1-e12. doi: 10.9777/chd.2019.1015. Cancer Health Disparities. 2019. PMID: 31485577 Free PMC article.
-
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans.Cancer Res. 2000 Feb 15;60(4):950-6. Cancer Res. 2000. PMID: 10706110
-
Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):711-4. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11401924
-
Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.Clin Chem Lab Med. 2000 Sep;38(9):889-92. doi: 10.1515/CCLM.2000.129. Clin Chem Lab Med. 2000. PMID: 11097345 Review.
-
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.Oncology (Williston Park). 2003 May;17(5 Suppl 5):52-5. Oncology (Williston Park). 2003. PMID: 12800608 Review.
Cited by
-
Prevalence of the UGT1A1*28 promoter polymorphism and breast cancer risk among African American women in Memphis, TN.Cancer Health Disparities. 2019 Aug 19;3:e1-e12. doi: 10.9777/chd.2019.1015. Cancer Health Disparities. 2019. PMID: 31485577 Free PMC article.
References
-
- Cancer facts and figures (2010) American Cancer Society.
-
- Reznikoff CA, Sarkar S, Jülicher KP, Burger MS, Puthenveettil JA, et al. (2000) Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol 5: 191–203. - PubMed
-
- Feigelson H, Henderson B (1996) Estrogens and breast cancer. Carcinogenesis 17: 2279–2284. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources